Measuring and predicting personal and household Black Carbon levels from 88 communities in eight countries.


Journal

The Science of the total environment
ISSN: 1879-1026
Titre abrégé: Sci Total Environ
Pays: Netherlands
ID NLM: 0330500

Informations de publication

Date de publication:
20 Apr 2022
Historique:
received: 18 10 2021
revised: 16 11 2021
accepted: 17 11 2021
pubmed: 26 11 2021
medline: 11 3 2022
entrez: 25 11 2021
Statut: ppublish

Résumé

Black Carbon (BC) is an important component of household air pollution (HAP) in low- and middle- income countries (LMICs), but levels and drivers of exposure are poorly understood. As part of the Prospective Urban and Rural Epidemiological (PURE) study, we analyzed 48-hour BC measurements for 1187 individual and 2242 household samples from 88 communities in 8 LMICs (Bangladesh, Chile, China, Colombia, India, Pakistan, Tanzania, and Zimbabwe). Light absorbance (10

Identifiants

pubmed: 34822894
pii: S0048-9697(21)06925-4
doi: 10.1016/j.scitotenv.2021.151849
pii:
doi:

Substances chimiques

Air Pollutants 0
Particulate Matter 0
Carbon 7440-44-0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

151849

Informations de copyright

Copyright © 2021. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors have no conflicts of interest to declare.

Auteurs

Ying Wang (Y)

College of Public Health and Human Sciences, Oregon State University, Corvallis, OR, United States.

Matthew Shupler (M)

School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada; Department of Public Health, Policy and Systems, University of Liverpool, Liverpool, United Kingdom.

Aaron Birch (A)

School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada.

Yen Li Chu (YL)

School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada.

Matthew Jeronimo (M)

School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada.

Sumathy Rangarajan (S)

Population Health Research Institute, Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada.

Maha Mustaha (M)

Population Health Research Institute, Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada.

Laura Heenan (L)

Population Health Research Institute, Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada.

Pamela Seron (P)

Universidad de La Frontera, Temuco, Chile.

Fernando Lanas (F)

Universidad de La Frontera, Temuco, Chile.

Luis Salazar (L)

Universidad de La Frontera, Temuco, Chile.

Nicolas Saavedra (N)

Universidad de La Frontera, Temuco, Chile.

Maria Jose Oliveros (MJ)

Universidad de La Frontera, Temuco, Chile.

Patricio Lopez-Jaramillo (P)

Universidad de Santander (UDES), Bucaramanga, Colombia.

Paul A Camacho (PA)

Fundación Oftalmológica de Santander (FOSCAL), Floridablanca, Colombia.

Johnna Otero (J)

Fundación Oftalmológica de Santander (FOSCAL), Floridablanca, Colombia.

Maritza Perez-Mayorga (M)

Facultad de Medicina Universidad Militar Nueva Granada and Clinica de Marly, Bogota, Colombia.

Karen Yeates (K)

Pamoja Tunaweza Research Centre, Moshi, Tanzania; Department of Medicine, Queen's University, Kingston, Ontario, Canada.

Nicola West (N)

Pamoja Tunaweza Research Centre, Moshi, Tanzania.

Tatenda Ncube (T)

Department of Biomedical Sciences, University of Zimbabwe, Harare, Zimbabwe.

Brian Ncube (B)

Department of Biomedical Sciences, University of Zimbabwe, Harare, Zimbabwe.

Jephat Chifamba (J)

Department of Biomedical Sciences, University of Zimbabwe, Harare, Zimbabwe.

Rita Yusuf (R)

School of Life Sciences, Independent University, Dhaka, Bangladesh.

Afreen Khan (A)

School of Life Sciences, Independent University, Dhaka, Bangladesh.

Zhiguang Liu (Z)

Beijing An Zhen Hospital of the Capital University of Medical Sciences, China.

Hu Bo (H)

Medical Research & Biometrics Center, National Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences, China.

Li Wei (L)

Medical Research & Biometrics Center, National Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences, China.

L A Tse (LA)

Jockey Club School of Public health and Primary Care, the Chinese University of Hong Kong, HKSAR, China.

Deepa Mohan (D)

Madras Diabetes Research Foundation, Chennai, India.

Parthiban Kumar (P)

Madras Diabetes Research Foundation, Chennai, India.

Rajeev Gupta (R)

Eternal Heart Care Centre & Research Institute, Jaipur, India.

Indu Mohan (I)

Mahatma Gandhi University of Medical Sciences and Technology, Jaipur, India.

K G Jayachitra (KG)

St. John's Medical College & Research Institute, Bangalore, India.

Prem K Mony (PK)

St. John's Medical College & Research Institute, Bangalore, India.

Kamala Rammohan (K)

Health Action By People, Government Medical College, Trivandrum, India.

Sanjeev Nair (S)

Health Action By People, Government Medical College, Trivandrum, India.

P V M Lakshmi (PVM)

Post Graduate Institute of Medical Education and Research, Chandigarh, India.

Vivek Sagar (V)

Post Graduate Institute of Medical Education and Research, Chandigarh, India.

Rehman Khawaja (R)

Department of Community Health Science, Aga Khan University Hospital, Karachi, Pakistan.

Romaina Iqbal (R)

Department of Community Health Science, Aga Khan University Hospital, Karachi, Pakistan.

Khawar Kazmi (K)

Department of Community Health Science, Aga Khan University Hospital, Karachi, Pakistan.

Salim Yusuf (S)

Population Health Research Institute, Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada.

Michael Brauer (M)

School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada.

Perry Hystad (P)

College of Public Health and Human Sciences, Oregon State University, Corvallis, OR, United States. Electronic address: perry.hystad@oregonstate.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH